Curocell KRX:372320KOSDAQ
큐로셀 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days1
Articles tracked1since Sep 11
In Q2 2026, Curocell reported revenue of ₩0m and an operating loss of ₩9.7bn. Curocell (큐로셀) appeared in 1 Korean news article and 1 DART filing over the past seven days. Coverage peaked on Sep 14 with 1 article.
Curocell quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩0m | – | −₩9.7bn | −₩17.6bn |
| Q1 2026 | ₩0m | – | −₩7.8bn | −₩8.7bn |
| Q4 2025 derived | ₩0m | – | −₩8.7bn | −₩17.5bn |
| Q3 2025 | ₩0m | – | −₩9.2bn | −₩10.2bn |
| Q2 2025 | ₩0m | – | −₩12.1bn | −₩11.8bn |
| Q1 2025 | ₩0m | – | −₩6.2bn | −₩6.8bn |
| Q4 2024 derived | ₩0m | – | −₩10.0bn | −₩10.5bn |
| Q3 2024 | ₩0m | – | −₩10.0bn | −₩10.4bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Curocell top stories 2 weeks, by number of outlets
- 1
